BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 32155667)

  • 1. Accelerated robust optimization algorithm for proton therapy treatment planning.
    Buti G; Souris K; Barragán Montero AM; Cohilis M; Lee JA; Sterpin E
    Med Phys; 2020 Jul; 47(7):2746-2754. PubMed ID: 32155667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Towards fast and robust 4D optimization for moving tumors with scanned proton therapy.
    Buti G; Souris K; Montero AMB; Lee JA; Sterpin E
    Med Phys; 2019 Dec; 46(12):5434-5443. PubMed ID: 31595521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statistical evaluation of worst-case robust optimization intensity-modulated proton therapy plans using an exhaustive sampling approach.
    Yang Z; Li H; Li Y; Li Y; Chang Y; Li Q; Yang K; Wu G; Sahoo N; Poenisch F; Gillin M; Zhu XR; Zhang X
    Radiat Oncol; 2019 Jul; 14(1):129. PubMed ID: 31324257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Minimax optimization for handling range and setup uncertainties in proton therapy.
    Fredriksson A; Forsgren A; Hårdemark B
    Med Phys; 2011 Mar; 38(3):1672-84. PubMed ID: 21520880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Technical Note: Treatment planning system (TPS) approximations matter - comparing intensity-modulated proton therapy (IMPT) plan quality and robustness between a commercial and an in-house developed TPS for nonsmall cell lung cancer (NSCLC).
    Liu C; Yu NY; Shan J; Bhangoo RS; Daniels TB; Chiang JS; Ding X; Lara P; Patrick CL; Archuleta JP; DeWees T; Hu Y; Schild SE; Bues M; Sio TT; Liu W
    Med Phys; 2019 Nov; 46(11):4755-4762. PubMed ID: 31498885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intensity-modulated proton therapy (IMPT) interplay effect evaluation of asymmetric breathing with simultaneous uncertainty considerations in patients with non-small cell lung cancer.
    Shan J; Yang Y; Schild SE; Daniels TB; Wong WW; Fatyga M; Bues M; Sio TT; Liu W
    Med Phys; 2020 Nov; 47(11):5428-5440. PubMed ID: 32964474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Automated proton treatment planning with robust optimization using constrained hierarchical optimization.
    Taasti VT; Hong L; Deasy JO; Zarepisheh M
    Med Phys; 2020 Jul; 47(7):2779-2790. PubMed ID: 32196679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment planning and 4D robust evaluation strategy for proton therapy of lung tumors with large motion amplitude.
    Taasti VT; Hattu D; Vaassen F; Canters R; Velders M; Mannens J; van Loon J; Rinaldi I; Unipan M; van Elmpt W
    Med Phys; 2021 Aug; 48(8):4425-4437. PubMed ID: 34214201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small spot size versus large spot size: Effect on plan quality for lung cancer in pencil beam scanning proton therapy.
    Rana S; Rosenfeld AB
    J Appl Clin Med Phys; 2022 Feb; 23(2):e13512. PubMed ID: 34989458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel and individualized robust optimization method using normalized dose interval volume constraints (NDIVC) for intensity-modulated proton radiotherapy.
    Shan J; Sio TT; Liu C; Schild SE; Bues M; Liu W
    Med Phys; 2019 Jan; 46(1):382-393. PubMed ID: 30387870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved healthy tissue sparing in proton therapy of lung tumors using statistically sound robust optimization and evaluation.
    Badiu V; Souris K; Buti G; Villarroel EB; Lambrecht M; Sterpin E
    Phys Med; 2022 Apr; 96():62-69. PubMed ID: 35227942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical implementation in proton therapy of multi-field optimization by a hybrid method combining conventional PTV with robust optimization.
    Tommasino F; Widesott L; Fracchiolla F; Lorentini S; Righetto R; Algranati C; Scifoni E; Dionisi F; Scartoni D; Amelio D; Cianchetti M; Schwarz M; Amichetti M; Farace P
    Phys Med Biol; 2020 Feb; 65(4):045002. PubMed ID: 31851957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Technical Note: 4D robust optimization in small spot intensity-modulated proton therapy (IMPT) for distal esophageal carcinoma.
    Feng H; Shan J; Ashman JB; Rule WG; Bhangoo RS; Yu NY; Chiang J; Fatyga M; Wong WW; Schild SE; Sio TT; Liu W
    Med Phys; 2021 Aug; 48(8):4636-4647. PubMed ID: 34058026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of respiratory motion on worst-case scenario optimized intensity modulated proton therapy for lung cancers.
    Liu W; Liao Z; Schild SE; Liu Z; Li H; Li Y; Park PC; Li X; Stoker J; Shen J; Keole S; Anand A; Fatyga M; Dong L; Sahoo N; Vora S; Wong W; Zhu XR; Bues M; Mohan R
    Pract Radiat Oncol; 2015; 5(2):e77-86. PubMed ID: 25413400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of linear and nonlinear programming approaches for "worst case dose" and "minmax" robust optimization of intensity-modulated proton therapy dose distributions.
    Zaghian M; Cao W; Liu W; Kardar L; Randeniya S; Mohan R; Lim G
    J Appl Clin Med Phys; 2017 Mar; 18(2):15-25. PubMed ID: 28300378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Robust intensity-modulated proton therapy to reduce high linear energy transfer in organs at risk.
    An Y; Shan J; Patel SH; Wong W; Schild SE; Ding X; Bues M; Liu W
    Med Phys; 2017 Dec; 44(12):6138-6147. PubMed ID: 28976574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Superiority in Robustness of Multifield Optimization Over Single-Field Optimization for Pencil-Beam Proton Therapy for Oropharynx Carcinoma: An Enhanced Robustness Analysis.
    Stützer K; Lin A; Kirk M; Lin L
    Int J Radiat Oncol Biol Phys; 2017 Nov; 99(3):738-749. PubMed ID: 29280468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Including robustness in multi-criteria optimization for intensity-modulated proton therapy.
    Chen W; Unkelbach J; Trofimov A; Madden T; Kooy H; Bortfeld T; Craft D
    Phys Med Biol; 2012 Feb; 57(3):591-608. PubMed ID: 22222720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Robust treatment planning with 4D intensity modulated carbon ion therapy for multiple targets in stage IV non-small cell lung cancer.
    Wolf M; Anderle K; Durante M; Graeff C
    Phys Med Biol; 2020 Nov; 65(21):215012. PubMed ID: 32610300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploratory Study of 4D versus 3D Robust Optimization in Intensity Modulated Proton Therapy for Lung Cancer.
    Liu W; Schild SE; Chang JY; Liao Z; Chang YH; Wen Z; Shen J; Stoker JB; Ding X; Hu Y; Sahoo N; Herman MG; Vargas C; Keole S; Wong W; Bues M
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):523-533. PubMed ID: 26725727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.